TY  - RPRT
TI  - The CIpP activator, TR-57, is highly effective as a single agent and in combination with venetoclax against CLL cells in vitro.
AU  - Fatima, N.
AU  - Shen, Y.
AU  - Crassini, K.
AU  - Iwanowicz, E.
AU  - Lang, H.
AU  - Karanewsky, D.
AU  - Christopherson, R.
AU  - Mulligan, S.
AU  - Best, G.
PY  - 2022
DO  - 10.1101/2022.03.07.483345
UR  - https://www.biorxiv.org/content/10.1101/2022.03.07.483345v1
ID  - 10.1101/2022.03.07.483345
ER  -